News in the Life Sciences Industry

- Bridging study results, published in the SCI journal, AP&T, demonstrate no racial differences exist in pharmacokinetic and pharmacodynamic properties of fexuprazan

SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners in China at the third China International Import Expo (CIIE) in Shanghai. These latest collaborations,... Read more ››

BRUSSELS, Nov. 5, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its TNF inhibitor, CIMZIA(® )(certolizumab pegol), and investigational IL-17A and IL-17F inhibitor, bimekizumab. Data are being presented at the American College of Rheumatology... Read more ››

MUMBAI, India and MUNICH, Nov. 4, 2020 /PRNewswire/ -- TÜV SÜD Product Service has issued their first In Vitro Medical Device Regulation (IVDR) certificate since receiving notification in June 2020 - and the first IVDR certificate worldwide. The IVDR, which came into force in May 2017,... Read more ››

PRAGUE, Nov. 4, 2020 /PRNewswire/ -- Zentiva has received the 2020 Global Generics & Biosimilars Bulletin Award in the category of EMEA Acquisition of the year. In Q2 2020, during the peak of the first wave of the COVID-19 crisis, Zentiva completed the acquisition of Alvogen CEE that brought... Read more ››

Three challenges to contribute to pharmaceutical research and innovation.

DUBLIN, Nov. 2, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2020 and updated its 2020 financial guidance.